Sunshine Biopharma Inc. — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Form 8-K filed 2026-09-16 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) with period of report 2026-09-15. The filing contains no substantive disclosure of what matters were submitted, vote counts, percentages, or outcomes—only SEC filing metadata and XBRL formatting documents.
Why this rating
8-K filed but actual voting matter details absent from submission text; cannot assess materiality without knowing what was voted on or results.
Extracted items
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.